TrialScope Ends 2020 with Strongest Year of Customer Growth


March 8, 2021

16 New Clinical Trial Sponsors Managing Disclosure and Transparency
with SaaS Platform

Jersey City, NJ, March 8, 2021 — TrialScope, the global leader in clinical trial disclosure and transparency technology, has acquired 16 new customers — 10 in Q4 alone —across its disclosure, transparency and recruitment solutions. Beigene, FibroGen, Gilead and  Moderna are among the newest customers who rely upon TrialScope solutions including clinical trial disclosure management, clinical trial awareness and transparency, and patient recruitment.

In addition, several of the sponsors are taking advantage of TrialScope’s Disclosure Services. These services, managed by TrialScope experts in clinical trial disclosure, feature protocol registration, study results disclosure, plain-language summaries (PLS), and redaction and anonymization of study data for submission to regulatory agencies.

TrialScope’s customers run the gamut from specialized biotechs to global pharmaceutical companies. Collectively, TrialScope customers are responsible for more than 40 percent of all industry trials on and the EU-CTR. More than 12,000 users manage 67,000-plus trials using TrialScope technology.

“We welcome all of our new business partners to the TrialScope community,” said TrialScope Chief Commercial Officer Chris Venezia. “While many companies were hit hard last year due to the coronavirus pandemic, TrialScope has had the good fortune of expanding our customer base. I attribute this to the unparalleled quality of our products and services, as well as to the dedication of our entire staff. Although we were forced to work remotely, it did not deter our team members from their unwavering commitment to our customers.”

About TrialScope 

TrialScope gives your clinical trial data superpowers™. We make centralizing, structuring and activating clinical trial information simple, for use across the organization and at every stage of the study. Our integrated platform is used by 17 of the top 20 clinical trial sponsors in the world, who rely on TrialScope to ensure disclosure compliance, maximize trial transparency, improve patient engagement and accelerate study recruitment. To learn more, visit

TrialScope was acquired by Informa Pharma Intelligence in 2020, combining its powerful technology for disclosure, transparency and recruitment with leading brands, data and solutions for the clinical trials and broader pharmaceutical and biomedical industry.

About Informa Pharma Intelligence

Informa Pharma Intelligence powers a full suite of analysis products—Datamonitor Healthcare™, Sitetrove™, Trialtrove™, Pharmaprojects™, Medtrack™, Biomedtracker™, Scrip™, Pink Sheet™ In Vivo™ and most recently TrialScope—to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth. With more than 500 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isn’t covered through the breadth and depth of data available to customers. For more information visit